Literature DB >> 25832850

Vitamin D, Low-Grade Inflammation and Cardiovascular Risk in Young Children: A Pilot Study.

Jasmine Singh1, Eric Dean Merrill2, Pratik B Sandesara2, Laura Schoeneberg2, Hongying Dai2,3, Geetha Raghuveer2,3.   

Abstract

Vitamin D has anti-inflammatory properties, and deficiency is prevalent in children. There is a paucity of data regarding vitamin D status and its correlation with low-grade inflammation and vasculature. We prospectively enrolled 25 children, 9-11 years old (13 male); 21 obese. Eight atherosclerosis-promoting risk factors were scored as categorical variables with the following thresholds defining abnormality: body mass index Z score ≥ 1.5; systolic blood pressure ≥ 95th percentile (for age, sex, and height); triglyceride ≥ 100 mg/dL; low-density lipoprotein cholesterol (LDL-C) ≥ 110 mg/dL; high-density lipoprotein cholesterol ≤ 45 mg/dL; hemoglobin A1C (HBA1C) ≥ 5.5; 25-hydroxyvitamin D [25(OH) D] ≤ 30 ng/mL, and tobacco smoke exposure. High-sensitivity C-reactive protein (hsCRP) was measured to assess low-grade inflammation and classified as low- (<1 mg/L), average- (1-3 mg/L), and high-risk (>3 to <10 mg/L) groups. The proportion of children within each hsCRP group who had above threshold risk factors was calculated. Carotid artery ultrasound was performed to measure carotid artery intima-media thickness (CIMT). Median (range) for 25(OH) D was 24 (17-45) ng/mL. Eighteen were either 25 (OH) D deficient (<20 ng/mL) or insufficient (20-30 ng/mL), and seven were sufficient (>30 ng/mL). hsCRP was 1.7 (0.2-9.1) mg/L, with 11 being <1.0 mg/L, 8 between 1.0-3.0 and 6 > 3.0 to < 10.0 mg/L. Risk factor score was 3.9 ± 1.7 out of eight. 25(OH) D levels did not correlate with hsCRP or CIMT. While vitamin D deficiency, inflammation, and risk factors coexist at a very young age, causative mechanisms remain unclear.

Entities:  

Keywords:  CIMT; Obesity; Pediatrics; Risk factors; Vitamin D; hsCRP

Mesh:

Substances:

Year:  2015        PMID: 25832850     DOI: 10.1007/s00246-015-1162-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  31 in total

1.  A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes.

Authors:  Stylianos Kapiotis; Gregor Holzer; Georg Schaller; Markus Haumer; Harald Widhalm; Daniel Weghuber; Bernd Jilma; Georg Röggla; Michael Wolzt; Kurt Widhalm; Oswald F Wagner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-14       Impact factor: 8.311

2.  Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure.

Authors:  Thomas Reinehr; Wieland Kiess; Gideon de Sousa; Birgit Stoffel-Wagner; Ranier Wunsch
Journal:  Metabolism       Date:  2006-01       Impact factor: 8.694

Review 3.  Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies.

Authors:  Lu Wang; Yiqing Song; Joann E Manson; Stefan Pilz; Winfried März; Karl Michaëlsson; Annamari Lundqvist; Simerjot K Jassal; Elizabeth Barrett-Connor; Cuilin Zhang; Charles B Eaton; Heidi T May; Jeffrey L Anderson; Howard D Sesso
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-11-13

4.  Decreased bioavailability of vitamin D in obesity.

Authors:  J Wortsman; L Y Matsuoka; T C Chen; Z Lu; M F Holick
Journal:  Am J Clin Nutr       Date:  2000-09       Impact factor: 7.045

5.  Elevated serum C-reactive protein levels and early arterial changes in healthy children.

Authors:  Mikko J Järvisalo; Aimo Harmoinen; Maarit Hakanen; Ulla Paakkunainen; Jorma Viikari; Jaakko Hartiala; Terho Lehtimäki; Olli Simell; Olli T Raitakari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-08-01       Impact factor: 8.311

6.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

Authors:  G S Berenson; S R Srinivasan; W Bao; W P Newman; R E Tracy; W A Wattigney
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

7.  Effects of diet and exercise on obesity-related vascular dysfunction in children.

Authors:  Kam S Woo; Ping Chook; Chung W Yu; Rita Y T Sung; Mu Qiao; Sophie S F Leung; Christopher W K Lam; Con Metreweli; David S Celermajer
Journal:  Circulation       Date:  2004-04-05       Impact factor: 29.690

8.  Prevention of rickets and vitamin D deficiency in infants, children, and adolescents.

Authors:  Carol L Wagner; Frank R Greer
Journal:  Pediatrics       Date:  2008-11       Impact factor: 7.124

9.  Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials.

Authors:  Pei-Juan Mao; Chi Zhang; Lan Tang; Yu-Qiong Xian; Yan-Song Li; Wei-Dong Wang; Xiu-Hua Zhu; Hua-Li Qiu; Jia He; Yu-Hao Zhou
Journal:  Int J Cardiol       Date:  2013-08-27       Impact factor: 4.164

10.  The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study.

Authors:  D S Freedman; W H Dietz; R Tang; G A Mensah; M G Bond; E M Urbina; S Srinivasan; G S Berenson
Journal:  Int J Obes Relat Metab Disord       Date:  2004-01
View more
  3 in total

1.  Vitamin D Supplementation on Carotid Remodeling and Stiffness in Obese Adolescents.

Authors:  Christopher Morrissey; Marie-Josèphe Amiot; Aurelie Goncalves; Cecile Raverdy; Delphine Masson; Catherine Tardivel; Sandrine Gayrard; Myriam Carrère; Jean-Francois Landrier; Agnes Vinet; Antonia Perez-Martin
Journal:  Nutrients       Date:  2022-05-30       Impact factor: 6.706

2.  Associations of Dietary Intake on Biological Markers of Inflammation in Children and Adolescents: A Systematic Review.

Authors:  Melissa Bujtor; Anne I Turner; Susan J Torres; Laura Esteban-Gonzalo; Carmine M Pariante; Alessandra Borsini
Journal:  Nutrients       Date:  2021-01-25       Impact factor: 5.717

Review 3.  Can dietary intake protect against low-grade inflammation in children and adolescents?

Authors:  Melissa Bujtor
Journal:  Brain Behav Immun Health       Date:  2021-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.